Determination of the Safety and Efficacy of Two Probiotic Strains
← catalyst calendarSponsored by The Archer-Daniels-Midland Company (industry) · ADM — their whole pipeline →. With Merieux NutriSciences (China).
Phase
Not applicable
Status
Unknown status
Study type
Interventional
Design
Randomized · Triple · Basic science
Enrollment
100estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jun 2024 | estimated | When the study began enrolling |
| Primary completion | May 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | May 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2024-06-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-06-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Gastrointestinal Dysfunction
Interventions
- Dietary supplement: Placebo 1 to Probiotic A
- Dietary supplement: Probiotic A to Placebo 1
- Dietary supplement: Placebo 2 to Probiotic B
- Dietary supplement: Probiotic B to Placebo 2
Primary outcome
what the primary-completion date above is the date OFChange in GSRS-IBS score
measured Baseline vs Week 6
Permalink · ADM's whole pipeline · Catalyst calendar · Every registered study · What changed